These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 19340897)

  • 21. Incidence and risk factors of Clostridium difficile infection in patients with inflammatory bowel disease.
    Stoica O; Trifan A; Cojocariu C; Gîrleanu I; Maxim R; Stanciu MC
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):81-6. PubMed ID: 25970947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mice with Inflammatory Bowel Disease are Susceptible to Clostridium difficile Infection With Severe Disease Outcomes.
    Zhou F; Hamza T; Fleur AS; Zhang Y; Yu H; Chen K; Heath JE; Chen Y; Huang H; Feng H
    Inflamm Bowel Dis; 2018 Feb; 24(3):573-582. PubMed ID: 29462386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histological features of Clostridioides difficile colitis in patients with inflammatory bowel disease.
    Sweeney JR; Crawford CV; Yantiss RK
    Histopathology; 2022 Sep; 81(3):312-318. PubMed ID: 35758181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An epidemic, toxin gene-variant strain of Clostridium difficile.
    McDonald LC; Killgore GE; Thompson A; Owens RC; Kazakova SV; Sambol SP; Johnson S; Gerding DN
    N Engl J Med; 2005 Dec; 353(23):2433-41. PubMed ID: 16322603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission.
    Clayton EM; Rea MC; Shanahan F; Quigley EM; Kiely B; Hill C; Ross RP
    Am J Gastroenterol; 2009 May; 104(5):1162-9. PubMed ID: 19319128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with prolonged symptoms and severe disease due to Clostridium difficile.
    Kyne L; Merry C; O'Connell B; Kelly A; Keane C; O'Neill D
    Age Ageing; 1999 Mar; 28(2):107-13. PubMed ID: 10350405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for Clostridium difficile-associated diarrhea among hospitalized adults with fecal toxigenic C. difficile colonization.
    Lin HJ; Hung YP; Liu HC; Lee JC; Lee CI; Wu YH; Tsai PJ; Ko WC
    J Microbiol Immunol Infect; 2015 Apr; 48(2):183-9. PubMed ID: 24064285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clostridium difficile infection.
    Smits WK; Lyras D; Lacy DB; Wilcox MH; Kuijper EJ
    Nat Rev Dis Primers; 2016 Apr; 2():16020. PubMed ID: 27158839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for Clostridioides difficile infection and colonization among patients admitted to an intensive care unit in Shanghai, China.
    Cui Y; Dong D; Zhang L; Wang D; Jiang C; Ni Q; Wang C; Mao E; Peng Y
    BMC Infect Dis; 2019 Nov; 19(1):961. PubMed ID: 31711425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current Diagnostic and Treatment Approach of Clostridioides difficile Infection.
    Yunita B; Fauzi A
    Acta Med Indones; 2023 Apr; 55(2):231-238. PubMed ID: 37524596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review: Clostridium difficile-associated disorders/diarrhea and Clostridium difficile colitis: the emergence of a more virulent era.
    Hookman P; Barkin JS
    Dig Dis Sci; 2007 Apr; 52(4):1071-5. PubMed ID: 17380404
    [No Abstract]   [Full Text] [Related]  

  • 32. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.
    Loo VG; Poirier L; Miller MA; Oughton M; Libman MD; Michaud S; Bourgault AM; Nguyen T; Frenette C; Kelly M; Vibien A; Brassard P; Fenn S; Dewar K; Hudson TJ; Horn R; René P; Monczak Y; Dascal A
    N Engl J Med; 2005 Dec; 353(23):2442-9. PubMed ID: 16322602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical aspects of fulminant Clostridium difficile colitis.
    Butala P; Divino CM
    Am J Surg; 2010 Jul; 200(1):131-5. PubMed ID: 20409527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemic ribotypes of Clostridium (now Clostridioides) difficile are likely to be more virulent than non-epidemic ribotypes in animal models.
    Vitucci JC; Pulse M; Tabor-Simecka L; Simecka J
    BMC Microbiol; 2020 Feb; 20(1):27. PubMed ID: 32024477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.
    Goldenberg JZ; Ma SS; Saxton JD; Martzen MR; Vandvik PO; Thorlund K; Guyatt GH; Johnston BC
    Cochrane Database Syst Rev; 2013 May; (5):CD006095. PubMed ID: 23728658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolevamer, an anionic polymer, neutralizes toxins produced by the BI/027 strains of Clostridium difficile.
    Hinkson PL; Dinardo C; DeCiero D; Klinger JD; Barker RH
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2190-5. PubMed ID: 18391047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.
    Labbé AC; Poirier L; Maccannell D; Louie T; Savoie M; Béliveau C; Laverdière M; Pépin J
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3180-7. PubMed ID: 18573937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clostridioides difficile Colitis.
    Pumiglia L; Wilson L; Rashidi L
    Surg Clin North Am; 2024 Jun; 104(3):545-556. PubMed ID: 38677819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Critical Care Management of the Patient with Clostridioides difficile.
    Adelman MW; Woodworth MH; Shaffer VO; Martin GS; Kraft CS
    Crit Care Med; 2021 Jan; 49(1):127-139. PubMed ID: 33156122
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.